3 studies found for:    at-101 sclc
Show Display Options
Rank Status Study
1 Completed
Has Results
R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Drug: R-(-)-gossypol acetic acid;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study
2 Completed R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: R-(-)-gossypol acetic acid;   Drug: cisplatin;   Drug: etoposide
3 Completed Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: AT-101;   Drug: topotecan

Indicates status has not been verified in more than two years